# Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion

> **NCT05589207** · — · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 232 (estimated)

## Conditions studied

- Carcinoma, Renal Cell
- Tumor Thrombus
- Neoplasm Invasiveness
- Inferior Vena Cava Interruption

## Interventions

- **DIAGNOSTIC_TEST:** Vascular wall invaded

## Key facts

- **NCT ID:** NCT05589207
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2027-01-01
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589207, "Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall Invasion". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05589207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*